In a blog, the facility writes that MT2 isnt currently approved by the FDA. Additionally, West Lake Dermatology says that the compound cannot be legally marketed or sold as a drug, supplement, or cosmetic product. Further, it isnt used in standard medical practices. Its largely unregulated, with no reliable assurance of purity, sterility, or dosing. West Lake Dermatology writes that MT2 began its life as a peptide used for academic purposes
This is higher strength than regular alpha arbutin
For context, bariatric surgery typically results in 2530% weight loss, making retatrutide potentially competitive with surgical outcomesbut without the scalpel
Clinicians typically start patients at the middle ODT dose (5 mg) when switching from low-dose injectables (0.25 to 0.5 mg weekly) and titrate based on response
Each receptor in the triple agonist formula serves a distinct purpose
doi:10.1007/s13300-021-01190-z